Dr. Blake C. Alkire, MD

Dr. Alkire practices at Massachusetts Eye and Ear in Boston, Massachusetts, part of Mass General Brigham.

Dr. Alkire's NPI, 1649560707, was assigned on April 11, 2011. Dr. Alkire graduated from Harvard Medical School in 2011. Dr. Alkire's Massachusetts license number on file is 267176.

Dr. Alkire's primary practice is Massachusetts Eye and Ear, at 243 Charles Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 523-7900.

Dr. Alkire's primary practice is Massachusetts Eye and Ear in Boston, Massachusetts, part of Mass General Brigham. Dr. Alkire is also affiliated with Massachusetts General Hospital. Dmand AI also links Dr. Alkire to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alkire practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Alkire's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Alkire is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Alkire has a license on file in Massachusetts.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Alkire treats.

CMS data shows 677 Medicare services from Dr. Alkire across 8 procedure codes in 2024, for 339 Medicare patients. Medicare paid $35,835 for them. Every service was in an office.

CMS counts 339 Medicare patients who saw Dr. Alkire in 2024. The largest group is 65 to 74, with 143 patients. 69% of them have high cholesterol, and 61% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alkire's median patient age at 67, with 55% women.

In 2024, Dr. Alkire wrote 441 Medicare Part D claims for 162 patients. 100% of them were for generic drugs. CMS names the drug for 359 of them, across 8 drugs with 11 or more claims each, at $11,137 in total drug cost. In 2023, CMS named 273 claims across 8 drugs.

Dr. Alkire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alkire as offering telehealth.

Dmand AI links 66 papers to Dr. Alkire, published from 2011 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Global Health, Developing Countries and Health Expenditures. Dr. Alkire has published most often in Lancet Glob Health. Dr. Alkire's most frequent co-authors are John G. Meara, MD, Mary Jue Xu, MD and Taseer Feroze Din, MD.

CMS Open Payments shows 9 general payments to Dr. Alkire from 6 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Mylan Inc. paid the most, $55.

Dr. Alkire graduated from Harvard Medical School in 2011.

Dr. Alkire is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.